Career history of Richard Chesworth
Former positions of Richard Chesworth
| Companies | Position | Start | End |
|---|---|---|---|
| KYMERA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2020-08-26 | 2021-10-21 |
| EPIZYME, INC. | Chief Tech/Sci/R&D Officer | - | - |
Training of Richard Chesworth
| Imperial College London | Undergraduate Degree |
| University of Oxford | Doctorate Degree |
Statistics
International
| United States | 3 |
| United Kingdom | 3 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| KYMERA THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Richard Chesworth
- Experience
